Smoking cessation in pregnancy: Why, how, and what next...

Julie T. Crawford, Jorge E. Tolosa, Robert L. Goldenberg

Research output: Contribution to journalReview articlepeer-review

38 Scopus citations


Smoking cessation in pregnancy has been shown to reduce low birth weight, preterm birth, and infant morbidities. The effectiveness and safety profile of current cessation approaches in pregnancy are presented. The highest cessation rates are associated with counseling and behavioral interventions. Further studies are needed to evaluate the safety and efficacy of pharmacotherapy in pregnancy including nicotine replacement therapy, bupropion and the recently approved drug Varenicline. The risks and benefits of nicotine replacement therapy in heavy smokers and bupropion are discussed. Data on fetal risk are not yet available for Varenicline.

Original languageEnglish (US)
Pages (from-to)419-435
Number of pages17
JournalClinical obstetrics and gynecology
Issue number2
StatePublished - Jun 2008
Externally publishedYes


  • Bupropion
  • Cessation
  • Nicotine replacement therapy
  • Pregnancy
  • Smoking
  • Tobacco use
  • Varenicline

ASJC Scopus subject areas

  • Obstetrics and Gynecology


Dive into the research topics of 'Smoking cessation in pregnancy: Why, how, and what next...'. Together they form a unique fingerprint.

Cite this